Target intelligence / Profile preview

PSMG3 pseudogene 2 (PSMG3P2)

Target
PSMG3P2
Molecular classification
Other
01

Overview

PSMG3 pseudogene 2 (PSMG3P2) is annotated as a pseudogene, meaning it is a non-coding genomic element similar in sequence to the protein-coding gene PSMG3, but lacking coding potential and functional protein expression. Pseudogenes such as PSMG3P2 are generally not considered functional targets for drug discovery, are not known to encode proteins, are not part of canonical signaling, regulatory, or structural pathways, and have not been identified as actionable biomarkers, therapeutic targets, or disease drivers. The biological functions, disease roles, and interactions relevant to pseudogenes are generally uncharacterized unless specific regulatory RNA effects are discovered, which is not the case for PSMG3P2 based on available scientific data. PSMG3P2 should not be confused with PSMG3 (Proteasome assembly chaperone 3, also known as PAC3), which is a functional gene encoding a chaperone protein involved in proteasome assembly and has some implications in cancer biology[1][2][3]. No evidence supports PSMG3P2 as a protein, therapeutic target, or biomarker, and there is no reported drug interaction. If information is required on the functional gene (PSMG3), refer to that entity, not the pseudogene.

Other names
PSMG3P2PSMG3 pseudogene 2

Beyond the preview

Go deeper on PSMG3 pseudogene 2 (PSMG3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSMG3 pseudogene 2 (PSMG3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call